Citations

Citations to this article as recorded by  

• Persistence of activated anti‐mesothelin hYP218 chimeric antigen receptor T cells in the tumour is associated with efficacy in gastric and colorectal carcinomas
  Sameer Mir, Abhilash Venugopalan, Jingli Zhang, Nishanth Ulhas Nair, Manjistha Sengupta, Manakamana Khanal, Chaido Stathopoulou, Qun Jiang, Raffit Hassan
  Clinical and Translational Medicine.2024;[Epub]     CrossRef
• Targeting Mesothelin in Solid Tumours: Anti-mesothelin Antibody and Drug Conjugates
  Quincy Chu
  Current Oncology Reports.2023; 25(4): 309.     CrossRef
• High expression of mesothelin in plasma and tissue is associated with poor prognosis and promotes invasion and metastasis in gastric cancer
  Suryendu Saha, Chitranjan Mukherjee, Dipjit Basak, Prasun Panja, Pronoy Kanti Mondal, Ranajoy Ghosh, Aniket Halder, Abhijit Chowdhury, Gopal Krishna Dhali, Bitan Kumar Chattopadhyay, Saurabh Ghosh, Somsubhra Nath, Shalini Datta
  Advances in Cancer Biology - Metastasis.2023; 7: 100098.     CrossRef
• Novel Anti-Mesothelin Nanobodies and Recombinant Immunotoxins with Pseudomonas Exotoxin Catalytic Domain for Cancer Therapeutics
  Minh Quan Nguyen, Do Hyung Kim, Hye Ji Shim, Huynh Kim Khanh Ta, Thi Luong Vu, Thi Kieu Oanh Nguyen, Jung Chae Lim, Han Choe
  Molecules and Cells.2023; 46(12): 764.     CrossRef
• Immunotherapy for lung cancer: Focusing on chimeric antigen receptor (CAR)-T cell therapy
  Tongqing Xue, Xiang Zhao, Kun Zhao, Yan Lu, Juan Yao, Xianguo Ji
  Current Problems in Cancer.2022; 46(1): 100791.     CrossRef
• Cellular Immunotherapy in Gastric Cancer: Adoptive Cell Therapy and Dendritic Cell-Based Vaccination
  Elnaz Faghfuri, Mahdi Abdoli Shadbad, Amir Hossein Faghfouri, Narges Soozangar
  Immunotherapy.2022; 14(6): 475.     CrossRef
• Mesothelin Expression in Human Tumors: A Tissue Microarray Study on 12,679 Tumors
  Sören Weidemann, Pauline Gagelmann, Natalia Gorbokon, Maximilian Lennartz, Anne Menz, Andreas M. Luebke, Martina Kluth, Claudia Hube-Magg, Niclas C. Blessin, Christoph Fraune, Katharina Möller, Christian Bernreuther, Patrick Lebok, Till S. Clauditz, Frank
  Biomedicines.2021; 9(4): 397.     CrossRef
• Host Mesothelin Expression Increases Ovarian Cancer Metastasis in the Peritoneal Microenvironment
  Tyvette S. Hilliard, Brooke Kowalski, Kyle Iwamoto, Elizabeth A. Agadi, Yueying Liu, Jing Yang, Marwa Asem, Yuliya Klymenko, Jeff Johnson, Zonggao Shi, Gifty Marfowaa, Madeleine G. Yemc, Phillip Petrasko, M. Sharon Stack
  International Journal of Molecular Sciences.2021; 22(22): 12443.     CrossRef
• CAR-T Cell Therapy—An Overview of Targets in Gastric Cancer
  Dominika Bębnowska, Ewelina Grywalska, Paulina Niedźwiedzka-Rystwej, Barbara Sosnowska-Pasiarska, Jolanta Smok-Kalwat, Marcin Pasiarski, Stanisław Góźdź, Jacek Roliński, Wojciech Polkowski
  Journal of Clinical Medicine.2020; 9(6): 1894.     CrossRef
• Mesothelin-Targeted Recombinant Immunotoxins for Solid Tumors
  Brendan L. Hagerty, Guillaume J. Pegna, Jian Xu, Chin-Hsien Tai, Christine Alewine
  Biomolecules.2020; 10(7): 973.     CrossRef
• Phase I/II clinical trial of a Wilms’ tumor 1-targeted dendritic cell vaccination-based immunotherapy in patients with advanced cancer
  Wen Zhang, Xu Lu, Peilin Cui, Chunmei Piao, Man Xiao, Xuesong Liu, Yue Wang, Xuan Wu, Jingwei Liu, Lin Yang
  Cancer Immunology, Immunotherapy.2019; 68(1): 121.     CrossRef
• Mesothelin as a target for cervical cancer therapy
  Korinna Jöhrens, Lea Lazzerini, Jana Barinoff, Jalid Sehouli, Guenter Cichon
  Archives of Gynecology and Obstetrics.2019; 299(1): 211.     CrossRef
• A targeted proteomics approach reveals a serum protein signature as diagnostic biomarker for resectable gastric cancer
  Qiujin Shen, Karol Polom, Coralie Williams, Felipe Marques Souza de Oliveira, Mariana Guergova-Kuras, Frederique Lisacek, Niclas G. Karlsson, Franco Roviello, Masood Kamali-Moghaddam
  eBioMedicine.2019; 44: 322.     CrossRef
• Mesothelin as a biomarker for targeted therapy
  Jiang Lv, Peng Li
  Biomarker Research.2019;[Epub]     CrossRef
• Antibody drug conjugates under investigation in phase I and phase II clinical trials for gastrointestinal cancer
  Alexis D. Leal, Anuradha Krishnamurthy, Lia Head, Wells A. Messersmith
  Expert Opinion on Investigational Drugs.2018; 27(11): 901.     CrossRef
• Mesothelin‑targeted second generation CAR‑T cells inhibit growth of mesothelin‑expressing tumors in�vivo
  Lin Ye, Yuqing Lou, Liming Lu, Xiaohong Fan
  Experimental and Therapeutic Medicine.2018;[Epub]     CrossRef

Carcinoma showing thymus-like differentiation (CASTLE) is a rare carcinoma of the thyroid or adjacent soft tissue of the neck with a histologic resemblance to thymic epithelial tumors. Although the fine-needle aspiration (FNA) plays a central role in the initial evaluation of thyroid nodules, few reports about the cytologic findings of CASTLE have been found according to a review of literatures. We report cytologic findings of a case of CASTLE. A 34-year-old woman presented with a 2-month history of sore throat. The FNA showed that the smear was composed of three dimensional clusters and sheets. The tumor cells were round to ovoid with high nuclear : cytoplasmic ratios. The nuclei were vesicular with small nucleoli. There were some tumor cells showing keratinization. Some lymphocytes were found on the background and within clusters. The presence of poorly-differentiated tumor cells with a focal keratinization and a lymphocytic background on the FNA is suggestive of CASTLE.

Citations

Citations to this article as recorded by  

• Coexistence of intrathyroid thymic carcinoma and papillary thyroid carcinoma: a case report and literature review
  Maryam Vajihinejad, Ali Ataei, Mohammad Pashmchi, Ali Aledavoud, Vahid Zand, Mohammad Ali Broomand, Mohammad Mohammadi, Niloofar Zare Reshkuiyeh
  Frontiers in Oncology.2024;[Epub]     CrossRef
• Intrathyroidal Thymic Carcinoma: A Retrospective Case Series Study
  Jinhui Liang, Mei Huang, Helang Huang, Li Li, Hailin Luo, Weidong Mao, Shan Gao, Haoxiang Xu
  Ear, Nose & Throat Journal.2023; 102(9): 584.     CrossRef
• Carcinoma showing thymus‐like differentiation of the parotid gland: The brief report of cytomorphology and review of the literature
  Tomoko Uchiyama, Chiyoko Terada, Yuma Tachibana, Hirokazu Nishiura, Maiko Takeda, Tomomi Fujii, Takahiro Kimura, Masahiro Tsutsumi, Chiho Ohbayashi
  Diagnostic Cytopathology.2023;[Epub]     CrossRef
• A case of concurrent occurrence of carcinoma showing thymus-like differentiation and follicular variant of papillary thyroid cancer in the same thyroid
  Takahito Kimura, Keisuke Enomoto, Masamitsu Kono, Masanobu Hiraoka, Saori Takeda, Naoko Kumashiro, Shun Hirayama, Eri Kimura, Shunji Tamagawa, Makiko Ohtani, Shin-Ichi Murata, Muneki Hotomi
  Journal of Surgical Case Reports.2022;[Epub]     CrossRef
• Ultrasonographic Features of Intrathyroidal Thymic Carcinoma: Review and Analysis of 10 Cases
  Wang, MD Yanhai, Yang, MD Hua, Liu, MD Hanqing, Luo, MD Xiaoli, Liu, BS Luying, Zhou, BS Pingting
  ADVANCED ULTRASOUND IN DIAGNOSIS AND THERAPY.2022; 6(2): 58.     CrossRef
• Thyroid carcinoma with thymus-like differentiation (CASTLE) tumor: а сase report
  A. A. Ilyin, V. V. Polkin, P. A. Isaev, F. E. Sevrukov, N. Yu. Dvinskych, M. I. Ryzhenkova, S. A. Ivanov, A. D. Kaprin
  Head and Neck Tumors (HNT).2021; 11(2): 64.     CrossRef
• Metastatic Renal Cell Neoplasm Within a Papillary Thyroid Carcinoma as Incidental Finding in an Asymptomatic Patient: a Case Report
  Maria-Rosa Bella-Cueto, Mireia Pascua-Solé, Albert Cano-Palomares, M. Àngels Cabezuelo-Hernandez, Maria-Rosa Escoda-Giralt, Santiago Barcons-Vilaplana, Paula Serret-Miralles, Carmen Caral-Vanaclocha, Xavier Guirao-Garriga, Joan Prats-Lopez, Meritxell Meda
  SN Comprehensive Clinical Medicine.2020; 2(7): 978.     CrossRef
• Intrathyroidal thymic carcinoma exhibiting neuroendocrine differentiation: Case report with cytomorphology, immunocytochemistry, and review of the literature focusing on cytology
  Wen‐hao Ren, Kun Dong, Xiao‐zheng Huang, Yan‐li Zhu
  Diagnostic Cytopathology.2019; 47(11): 1197.     CrossRef
• Management and Prognostic Factors for Thyroid Carcinoma Showing Thymus-Like Elements (CASTLE): A Case Series Study
  Rui Gao, Xi Jia, Ting Ji, Jinteng Feng, Aimin Yang, Guangjian Zhang
  Frontiers in Oncology.2018;[Epub]     CrossRef
• Multiple squamous cells in thyroid fine needle aspiration: Friends or foes?
  Heather Gage, Elizabeth Hubbard, Laurentia Nodit
  Diagnostic Cytopathology.2016; 44(8): 676.     CrossRef
• Clinical analysis of 82 cases of carcinoma showing thymus-like differentiation of the thyroid
  WEI GE, YONG-ZHONG YAO, GANG CHEN, YI-TAO DING
  Oncology Letters.2016; 11(2): 1321.     CrossRef
• Carcinoma Showing Thymus-Like Differentiation (CASTLE): Cytopathological Features and Differential Diagnosis
  Jennifer A. Collins, Bo Ping, Justin A. Bishop, Syed Z. Ali
  Acta Cytologica.2016; 60(5): 421.     CrossRef
• Carcinoma Showing Thymus-Like Elements of the Thyroid Gland: Report of Three Cases Including One Case with Breast Cancer History
  Guanjun Zhang, Xi Liu, Wei Huang, Xiaofeng Li, Marianne Johnstone, Yuan Deng, Yongqiang Ke, Quentin M. Nunes, Hongyan Wang, Yili Wang, Xuebin Zhang
  Pathology & Oncology Research.2015; 21(1): 45.     CrossRef
• Potential Role of Adjuvant Radiation Therapy in Cervical Thymic Neoplasm Involving Thyroid Gland or Neck
  Jae Myoung Noh, Sang Yun Ha, Yong Chan Ahn, Dongryul Oh, Seung Won Seol, Young Lyun Oh, Joungho Han
  Cancer Research and Treatment.2014; 47(3): 436.     CrossRef